BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Market News

GE Aerospace raises 2026 guidance as commercial services orders surge 58 percent

Moe Alsumidaie by Moe Alsumidaie
October 21, 2026
in Market News
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

GE Aerospace lifted full-year profit and cash flow targets after third-quarter orders jumped 58 percent, driven by a backlog of over $170 billion in commercial services work that the company now expects to grow low-double-digits into 2027. The raise signals confidence that demand for engine maintenance and spare parts will sustain momentum even as the company absorbs inflation and supply-chain constraints.

Third-quarter adjusted revenue climbed 18 percent to $13.3 billion, with Commercial Engines & Services revenue up 21 percent to $10.3 billion. Operating profit jumped 30 percent to $3.0 billion, lifting the operating margin 220 basis points to 22.5 percent. Adjusted earnings per share rose 36 percent to $2.25. For the full year, GE Aerospace now expects adjusted revenue growth of roughly 19 to 20 percent (up from a prior high-teens guide), adjusted operating profit of $10.9 billion to $11.0 billion (raised from $10.55 billion to $10.75 billion), and adjusted EPS of $8.00 to $8.10 (raised from $7.65 to $7.85). Free cash flow guidance rose to $9.1 billion to $9.4 billion from $8.9 billion to $9.2 billion.

What it means

The raise rests almost entirely on Commercial Engines & Services, which accounts for roughly three-quarters of revenue. Orders in that segment jumped 58 percent in the quarter, with services orders up 23 percent and equipment orders more than tripling. The company attributes the surge to commitments announced at Farnborough in July, including more than 1,000 LEAP-1A engines for IndiGo and over 300 LEAP-1B engines for Turkish Airlines, plus a $2.9 billion defense contract for F414 engine support. Revenue growth in CES accelerated to 21 percent, driven by a 12 percent rise in internal shop visit revenue (maintenance work performed in-house) and over 20 percent growth in spare parts, with LEAP-related work up over 40 percent.

The margin picture is more complicated. While adjusted operating profit margin expanded 220 basis points to 22.5 percent in the quarter, GAAP profit margin contracted 80 basis points to 19.9 percent. Management attributed the CES segment margin compression of 10 basis points to mix and inflation, even as volume and price gains drove profit up 21 percent. This suggests the company is absorbing cost pressures, material input from priority suppliers grew double-digits year-over-year, and the company is investing over $3 billion annually in R&D plus acquiring Consolidated Precision Products to expand casting capacity. The nine-month GAAP margin of 19.6 percent sits 200 basis points below the prior-year 21.6 percent, indicating that operational leverage from higher volume has not yet offset inflation and mix headwinds.

BullScope TerminalYou just read GENERAL ELECTRIC CO’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →

Defense & Propulsion Technologies, the smaller segment at roughly one-quarter of revenue, grew more modestly. Third-quarter revenue rose 7 percent to $3.5 billion, with operating profit up 8 percent and margin expanding 20 basis points to 13.7 percent. The company expects full-year DPT revenue growth of low double digits and operating profit of $1.6 billion to $1.7 billion, guidance unchanged from prior quarters. The segment’s slower pace suggests that commercial momentum is not yet translating to defense acceleration, though year-to-date orders in DPT rose 33 percent.

One open question the filing does not resolve: whether the margin compression from inflation and mix will persist or reverse as the company scales production and the CPP acquisition comes online. The guidance raise assumes operating profit margins will stabilize, but nine-month results show cumulative margin erosion despite strong revenue growth.

What to watch

Fourth-quarter results in January 2027 will show whether CES can deliver the “low 20s” revenue growth the company now expects for the full year, and whether margins stabilize or continue to compress. The filing does not quantify the margin impact of the CPP acquisition or the timing of GE9X engine revenue recognition post-certification, both of which could move full-year profit.

Source: the company’s 8-K filed 2026-10-20 with the SEC.

BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read GENERAL ELECTRIC CO’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie

Moe Alsumidaie

Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.

Recommended For You

Abbott to split Nutrition into independent company with $8.5 billion in sales by end of 2027

by Moe Alsumidaie
October 22, 2026
0

Abbott announced plans to separate its Nutrition business into a standalone publicly traded company by the end of 2027, creating a $8.5 bil

Read moreDetails

Biohaven licenses Japan and Asia rights to Graves’ disease candidate for $80 million upfront and 20% royalties

by Moe Alsumidaie
October 19, 2026
0

Biohaven has licensed its lead extracellular IgG degrader, BHV-1300, to Ono Pharmaceutical for exclusive development and commercialization

Read moreDetails

UnitedHealth’s operating margin surges as medical cost discipline offsets revenue decline

by Moe Alsumidaie
October 15, 2026
0

UnitedHealth Group raised full-year earnings guidance to at least $20.50 per share after third-quarter operating earnings jumped 53 percent

Read moreDetails

JPMorgan Chase’s third-quarter profit falls 28 percent as revenue slumps and credit costs rise

by Moe Alsumidaie
October 14, 2026
0

JPMorgan Chase reported net income of $15,305 million in the third quarter of 2026, down 28 percent from $21,155 million in the second quar

Read moreDetails

Delta’s September quarter revenue surges 16 percent on yield growth as fuel costs eat into margins

by Moe Alsumidaie
October 12, 2026
0

Delta Air Lines posted September quarter revenue of $17.6 billion, up 16 percent from the prior year, but the airline's adjusted operating

Read moreDetails
Next Post

Abbott's Split Personality: Revenue Climbs 14%, the Stock Falls Anyway

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Growing and Stuck: The Economy Is Doing Two Things at Once

August 27, 2026

The Frozen Market: What Home Depot’s Numbers Say About Housing’s Standoff

August 27, 2026

Ultragenyx: A Stock at Its Cheapest in a Decade, and the One Number That Explains Why

October 5, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.